Michael Mina (epidemiologist)
Michael Mina | |
|---|---|
| Born | Michael Joseph Mina |
| Alma mater | Dartmouth College Emory University |
| Scientific career | |
| Fields | Epidemiology, Ecology, Evolutionary biology, Genetics, Clinical pathology |
| Institutions | |
| Thesis | Cross-kingdom effects of a live attenuated viral vaccine on dynamics of and disease due to respiratory pathogens within divergent ecological domains: Introducing the generalized herd effect (2014) |
| Doctoral advisor | Keith P. Klugman |
Michael Joseph Mina is an American epidemiologist, immunologist and physician. He was formerly an assistant professor of Epidemiology & Immunology and Infectious Diseases at Harvard T.H. Chan School of Public Health, assistant Professor of Pathology at Brigham and Women's Hospital, Harvard Medical School, and currently Chief Medical Officer at eMed. and Chief Medical and Science Officer at Oncodea.
Mina is notable for his promotion of using rapid antigen tests to halt or slow the COVID-19 pandemic.